KIMIA BIOSCIENCES LIMITED Share Price

Kimia Biosciences Limited is an India-based company, which is engaged in the manufacturing of bulk drugs addressing various high-potential therapeutic segments. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), and Commercial KSMs, Intermediates and Reagents. The Company's Commercial-APIs products include Acotiamide Hydrochloride Hydrate, Azelnidipine, Benfotiamine, Benidipine Hydrochloride, Citicoline Sodium, Gliclazide, Dapagliflozin Propanediol Monohydrate, Levosulpiride, Luliconazole, Oxaceprol, Prucalopride Succinate, Teneligliptin Hydrobromide Hydrate, Vildagliptin, Fimasartan Trihydrate Potassium, Obeticholic Acid, Ursodeoxycholic Acid and others. Its Commercial KSMs, Intermediates and Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate; 2,4,5-Trimethoxy Benzoic Acid; Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate; Choline phosphate chloride calcium, and others.As of 26 May 2026, KIMIA BIOSCIENCES LIMITED share price is ₹35.69. The stock opened at ₹35.60, compared to its previous close of ₹34.77. During today's trading session, KIMIA BIOSCIENCES LIMITED share price moved in the range of ₹34.00 to ₹35.94, with an average price of ₹34.97 for the day. Looking at its last 52-week, the stock has touched a low of ₹34.00 and a high of ₹35.94.

The market capitalization of KIMIA BIOSCIENCES LIMITED is ₹165 Crs, with a P/E ratio of 18.2 and a dividend yield of 0.00%.